Shanghai plots to become biopharma R&D nexus of China
HONG KONG – Shanghai, the economic hub of China, wants to recreate itself into the biopharmaceutical development center of China, aiming to generate ¥350 billion (US$57.7 billion) in economic aggregate by the end of 2017.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter